Low-sodium diet in pregnancy: effects on blood pressure and maternal nutritional status

The British Journal of Nutrition
G D van der MatenJ G Hautvast

Abstract

In ninety-four Dutch nulliparous women the effects of a low-Na diet in pregnancy on blood pressure, energy and nutrient intake, Ca metabolism, Zn and Mg status and body composition were studied longitudinally. The women were randomly divided into an intervention group (n 41), which used a low-Na diet (mean urinary Na excretion 61 mmol/24 h) from week 14 of pregnancy until delivery and a control group (n 53; mean urinary Na excretion 142 mmol/24 h). No effect of the diet on blood pressure was observed. The use of a low-Na diet resulted in significantly reduced intakes of energy, protein, carbohydrates, fat, Ca, Zn, Mg, Fe and cholesterol. However, the women on the low-Na diet appeared to be able to adapt quite well to the reduced intake since Ca, Zn and Mg homeostasis was maintained. In the case of Ca and Mg this was probably due to the observed reduced urinary excretions of these nutrients. Non-significant reductions in weight gain (1.5 kg) and fat-mass gain (0.9 kg) over pregnancy were found in the women on the low-Na diet. No significant effects of the diet on birth weight or placental weight were observed.

References

Sep 6, 1979·The New England Journal of Medicine·H L BleichR W Gray
Apr 1, 1979·The American Journal of Clinical Nutrition·N W Solomons
Oct 1, 1978·Annals of Internal Medicine·A S PrasadM R Fox
Sep 1, 1992·American Journal of Obstetrics and Gynecology·B A ArmsonE K Main
Mar 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·J Verhaeghe, R Bouillon
Mar 1, 1991·The American Journal of Clinical Nutrition·C M TaylorI Bremner
Sep 1, 1990·The British Journal of Nutrition·M PanthB Sivakumar
Sep 1, 1989·The American Journal of Clinical Nutrition·E ForsumJ Wager
Mar 1, 1988·Clinical and Experimental Pharmacology & Physiology·C A Nowson, T O Morgan
Oct 17, 1987·Lancet·J V DurninG Fitzgerald
Oct 31, 1987·Lancet·K ThongprasertJ V Durnin
Nov 14, 1987·Lancet·M A TuazonC V Barba
Mar 1, 1988·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J M RoelofsenJ F Slegers
Apr 1, 1988·American Journal of Obstetrics and Gynecology·D A Davey, I MacGillivray
Feb 1, 1988·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·B StavricP Fried
May 1, 1987·The American Journal of Clinical Nutrition·P O Wester
May 1, 1987·American Journal of Obstetrics and Gynecology·M MarguliesR Schwarcz
Sep 1, 1985·British Journal of Obstetrics and Gynaecology·M Campbell-BrownJ C King
Jan 1, 1985·American Journal of Obstetrics and Gynecology·R M Pitkin
Mar 1, 1986·The American Journal of Clinical Nutrition·A J Clark, S Mossholder
Jan 1, 1985·The American Journal of Clinical Nutrition·J J CastenmillerG Schaafsma
Jan 15, 1985·American Journal of Obstetrics and Gynecology·J M MoutquinN Pelland
May 1, 1985·Clinical and Experimental Pharmacology & Physiology·P J McEnieryE S Boyce
Sep 1, 1985·The American Journal of Clinical Nutrition·A W CaggiulaH Langford
Sep 1, 1985·British Journal of Obstetrics and Gynaecology·W L SheldonT Lind
May 1, 1985·The British Journal of Nutrition·N F ButteC Garza
Jan 1, 1967·The British Journal of Nutrition·N R TaggartA M Thomson
Aug 1, 1969·The Journal of Obstetrics and Gynaecology of the British Commonwealth·J Ginsburg, S Duncan
Mar 1, 1966·American Journal of Clinical Pathology·H V Connerty, A R Briggs
Aug 1, 1967·The British Journal of Nutrition·J V Durnin, M M Rahaman
Apr 1, 1984·The American Journal of Clinical Nutrition·M T Baer, J C King
Mar 1, 1983·The American Journal of Clinical Nutrition·K M HambidgeD N Ikle
Aug 1, 1982·The Journal of Clinical Endocrinology and Metabolism·N A BreslauC Y Pak
May 1, 1980·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·H Ebel, T Günther
Dec 1, 1981·The American Journal of Clinical Nutrition·S C VirW Thompson
Mar 1, 1994·The British Journal of Nutrition·C J SpaaijJ G Hautvast
Jul 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H W Bruinse, H van den Berg
Oct 1, 1959·The Journal of Clinical Endocrinology and Metabolism·A G HILLSH CONOVER

❮ Previous
Next ❯

Citations

Jan 3, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H C Wallenburg
May 1, 2007·Annual Review of Nutrition·Elisabet Forsum, Marie Löf
Oct 20, 2005·The Cochrane Database of Systematic Reviews·L DuleyS Meher
Oct 22, 2014·The American Journal of Clinical Nutrition·Ellie GreshamAlexis J Hure
Jul 21, 2010·Deutsches Ärzteblatt International·Dieter KlausMartin Middeke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.